GEHCV GE HEALTHCARE TECHNOLOGIES INC

GE HealthCare Announces Collaboration with DePuy Synthes to Bring Advanced 3D Precision Imaging Innovation to Spine Practices in the United States

GE HealthCare (Nasdaq: GEHC) has entered into a distribution agreement with DePuy Synthes*, the Orthopaedics Company of Johnson & Johnson, to bring GE HealthCare’s OEC 3D Imaging System, in conjunction with DePuy Synthes’ extensive product portfolio, to more surgeons and patients across the United States. This new collaboration demonstrates GE HealthCare’s ongoing commitment to bring exceptional imaging technologies to clinicians providing patient care through the practice of some of healthcare’s most complex spine procedures today.

The spine is a crucial structure to the human body and highly complex in its composition of muscles, bones, tendons, ligaments, and sensitive nerves. Injuries or deformities of the spine can affect any appendage of the body and significantly restrict mobility as well as reduce quality of life as a result. Visualization and imaging are critical to helping achieve accurate diagnosis as well as treatment in the face of such complexity to ensure the most optimal patient outcome.

GE HealthCare’s OEC 3D Imaging System was designed to increase surgical imaging precision and efficiency to further the 3D imaging experience in surgical suites practicing spine procedures every day. The OEC 3D surgical imaging C-arm is a mobile CBCT imaging solution that works to seamlessly enable intraoperative 3D volumes and 2D high-definition imaging while covering a large anatomical field of view. With precise 3D volumetric images and familiar OEC 2D imaging capabilities, the OEC 3D C-arm also includes features for analyzing images, noise reduction, interoperative review, and seamless workflow to help clinicians see a broader picture.

With demand for minimally invasive surgical procedures continuing to grow and ambulatory surgery centers performing more than half of all outpatient procedures in the United States1, providers need efficient imaging capabilities. This new agreement will help enable both companies to better serve surgeons and address the complex needs of their patients and a wide range of procedural needs in spine.

“We know that GE HealthCare’s OEC 3D is a game-changer for clinicians today – from its large field of view and open platform to high-quality reconstructed 3D images,” said Phil Rackliffe, President & CEO for GE Healthcare’s Image-Guided Therapies business. “Through this new collaboration with DePuy Synthes, we’re excited for the opportunity to bring this technology to more spine practices in acute to outpatient settings knowing OEC 3D provides precise and efficient imaging so that surgeons can stay focused on what matters most, providing quality patient care.”

* DePuy Synthes represents the products and services of DePuy Synthes, Inc. and its affiliates.

______________________________

1

About GE HealthCare Technologies Inc.

GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 100 years, GE HealthCare is advancing personalized, connected, and compassionate care, while simplifying the patient’s journey across the care pathway. Together our Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics businesses help improve patient care from diagnosis, to therapy, to monitoring. We are an $18.3 billion business with 50,000 employees working to create a world where healthcare has no limits.

Follow us on , , , , and for the latest news, or visit our website for more information.

EN
21/06/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on GE HEALTHCARE TECHNOLOGIES INC

 PRESS RELEASE

GE HealthCare launches AI-driven, patient-friendly Invenia ABUS Premiu...

CHICAGO--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC) announced the launch of Invenia™ Automated Breast Ultrasound (ABUS) Premium, the latest 3D ultrasound offering advanced artificial intelligence (AI) and innovative features to drive faster*, reproducible supplemental screening and streamline exam readings on patients with dense breasts. Approximately 71% of cancers occur in dense breasts.1 According to studies across the U.S. and Europe, 40% of women2 and 70% of Asian women3 have dense breast tissue, making them four to six times more likely to receive a breast cancer diagnosis.4 Early d...

 PRESS RELEASE

GE HealthCare and NVIDIA reimagine diagnostic imaging with autonomous ...

SAN JOSE, Calif.--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC) today announced a collaboration with NVIDIA at GTC 2025, expanding the existing relationship between the two companies to focus on pioneering innovation in autonomous imaging, beginning with autonomous X-ray technologies and autonomous applications within ultrasound. GE HealthCare has been at the forefront of medical technology innovation with a series of “firsts” that date back more than a century, starting with the invention of its X-ray tube, followed by several others including the first handheld ultrasound, first 3D obstetr...

 PRESS RELEASE

GE HealthCare expands invasive cardiology solutions portfolio with Alt...

CHICAGO--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC) today announced the launch of the AltiX AI.i edition of Mac-Lab™, CardioLab™ and ComboLab™. The AltiX AI.i editions are designed to improve the user experience, elevating workflow in the cardiac catheterization (cath) lab and supporting even the most complex electrophysiology (EP) procedures. These latest editions offer new features that can streamline workflow and enhance interoperability, while upholding strong cybersecurity standards. Cardiovascular disease (CVD) has nearly doubled over the past three decades, affecting more than 500 ...

 PRESS RELEASE

GE HealthCare Advances Its Cloud Strategy by Unveiling the Genesis Por...

LAS VEGAS--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC) today announced its new Genesis solutions, a portfolio of cloud enterprise imaging software-as-a-service (SaaS) solutions. Four features will be offered when commercially released – edge, storage, vendor neutral archive and data migration.i These cloud solutions, are designed to help enhance healthcare organizations’ efficiency and precision, streamline workflows, and optimize the use of capital and IT resources. The growing volume and complexity of patient cases are putting increasing pressure on hospitals’ IT systems, driving the ne...

 PRESS RELEASE

GE HealthCare names new president and CEO, China

CHICAGO--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC), a leading global healthcare solutions provider, today announced that Yihao Zhang, president and CEO, China, will retire from the company effective July 1, 2025. Will Song, a Johnson & Johnson veteran for over 20 years, has been named GE HealthCare’s new president and CEO, China, and will join the company on April 1, 2025, ahead of leading the region starting July 1 following Yihao’s departure. Yihao’s planned retirement allowed GE HealthCare to purposefully identify and prepare a qualified successor in Will, an exceptional leader with ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch